Search by Drug Name or NDC

    NDC 00363-1011-24 NIGHTTIME COLD AND FLU 325; 10; 6.25; 5 mg/1; mg/1; mg/1; mg/1 Details

    NIGHTTIME COLD AND FLU 325; 10; 6.25; 5 mg/1; mg/1; mg/1; mg/1

    NIGHTTIME COLD AND FLU is a ORAL CAPSULE, LIQUID FILLED in the HUMAN OTC DRUG category. It is labeled and distributed by WALGREENS. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00363-1011
    Product ID 0363-1011_e1da33c7-5578-51fa-e053-2a95a90a7b4f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name NIGHTTIME COLD AND FLU
    Proprietary Name Suffix Maximum Strength
    Non-Proprietary Name ACETAMINOPHEN, DEXTROMETHORPHAN HBr, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCl
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, LIQUID FILLED
    Route ORAL
    Active Ingredient Strength 325; 10; 6.25; 5
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name WALGREENS
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00363-1011-24 (00363101124)

    NDC Package Code 0363-1011-24
    Billing NDC 00363101124
    Package 2 BLISTER PACK in 1 CARTON (0363-1011-24) / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
    Marketing Start Date 2022-06-23
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL dbf5c814-4e69-13ac-e053-2a95a90a49a3 Details

    Revised: 6/2022